Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexey Danilov
Institutions:
City Of Hope National Medical Center,
City of Hope
Observed institutions:
City Of Hope National Medical Center,
Oregon Health & Science University,
City of Hope,
OHSU Knight Cancer Institute
ORCID:
0000-0003-4461-0970
Observed ORCID:
0000-0003-4461-0970
OpenAlex ID:
A5148636539
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study
2026
·
Matthew Hamby
, Brian L. Egleston
, et al.
·
Blood Cancer Journal
·
3
PDF
Phenotype-guided subpopulation identification from single-cell sequencing data
2020
·
Duanchen Sun
, Xiangnan Guan
, et al.
·
Research Square
·
2
PDF
CLL-427: Updated Efficacy and Safety Data From an Ongoing Phase 1a/b Trial of the Bruton's Tyrosine Kinase Degrader Bexobrutideg (NX-5948) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Across Lines of Therapy
2026
·
Zulfa Omer
, Talha Munir
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CLL-427: Updated Efficacy and Safety Data From an Ongoing Phase 1a/b Trial of the Bruton's Tyrosine Kinase Degrader Bexobrutideg (NX-5948) in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Across Lines of Therapy
2026
·
Zulfa Omer
, Talha Munir
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma
2026
·
V Rakesh Sethapati
, Vu Ngo
, et al.
·
American Journal of Clinical Pathology
Abstract 1859: Overexpression of fructose transporter increases pro-survival signaling and confers venetoclax resistance in Ph-like B-cell acute lymphoblastic leukemia.
2026
·
Serene Xavier
, Sonia Rodriguez
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type